Skip to main content
Premium Trial:

Request an Annual Quote

Why Choose OA?

Open Access News points to an interview in PLoS with Oxford University's Jeremy Farrar, who is one of the journal's most frequently published authors. Here's what he had to say regarding open access publishing:

We are committed to the concept of truly open access journals, open from day one following publication and available to everyone anywhere. The follow on comments on the publications from readers is a superb feature and has already facilitated a series of discussions which never happen with the traditional publication system.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.